Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Compound 7p shows strong potential as an anticancer agent.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

CG2001 is safe and well-tolerated for treating hair loss in men.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Erlotinib can cause persistent excessive hair growth.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.